2-(4-Methylpiperidin-1-yl)-5-(trifluoromethyl)aniline, 250mg

4-n-Octyloxybenzonitrile, 98%, 5g

4-Ethylcyclohexanecarboxylic acid, 95.0%, 5g

4-Fluoro-3-phenylbenzoic acid, 98%, 100mg

2-(4,6-Dichloropyridin-3-yl)acetonitrile, 95.0%, 250mg

4-Bromoisophthalic Acid>97.0%(GC)(T)25g

2-Bromo-9,9-dimethyl-5-phenyl-9H-fluorene, 98%, 25g

1-Bromo-4-fluoro-2-iodobenzene>98.0%(GC)25g

2-(3-Chlorophenyl)-5-methyl-2H-pyrazol-3-yl amine, 5g

(2E)-1-(2,5-dimethoxyphenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 10g

Manganese(II) acetate tetrahydrate, min. 99%, ultra pure, 500 g, plastic packaging.

N-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)phenyl)quinoline-2-carboxamide, 98%, 250mg

(4S,9aS)-4-Aminohexahydro-1H,5H-pyrrolo[2,1-c][1,4]oxazepin-5-one, 98%, 1g